ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 25 filers reported holding ARCA BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 8.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,486 | -30.9% | 28,600 | -30.2% | 0.00% | – |
| Q2 2023 | $83,230 | -65.2% | 41,000 | -65.9% | 0.00% | – |
| Q1 2023 | $238,999 | +10.7% | 120,100 | +31.3% | 0.00% | – |
| Q4 2022 | $215,940 | -91.7% | 91,500 | -92.7% | 0.00% | – |
| Q3 2022 | $2,588,000 | -15.6% | 1,256,413 | +2.0% | 0.00% | -100.0% |
| Q2 2022 | $3,068,000 | +1200.0% | 1,232,017 | +1105.5% | 0.00% | – |
| Q1 2022 | $236,000 | -56.5% | 102,200 | -59.5% | 0.00% | – |
| Q4 2021 | $542,000 | 0.0% | 252,334 | +37.8% | 0.00% | – |
| Q3 2021 | $542,000 | -2.7% | 183,135 | +14.7% | 0.00% | – |
| Q2 2021 | $557,000 | +7.3% | 159,647 | +12.2% | 0.00% | – |
| Q1 2021 | $519,000 | +45.0% | 142,302 | +59.0% | 0.00% | – |
| Q4 2020 | $358,000 | – | 89,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SG3 Management, LLC | 100,000 | $249,000 | 0.03% |
| Murchinson Ltd. | 50,593 | $126,000 | 0.02% |
| Marquette Asset Management, LLC | 17,318 | $43,000 | 0.01% |
| SG3 Management, LLC | 22,706 | $57,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $117,000 | 0.00% |
| Tekla Capital Management LLC | 32,461 | $81,000 | 0.00% |
| BAILARD, INC. | 35,000 | $87,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 131,501 | $327,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,238 | $25,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 882,900 | $2,198,000 | 0.00% |